Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme

dc.contributor.authorKilickap, Saadettin
dc.contributor.authorOztoprak, Ibrahim
dc.contributor.authorYucel, Birsen
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T10:03:54Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T10:03:54Z
dc.date.issued2012
dc.department[Kilickap, Saadettin] Cumhuriyet Univ, Fac Med, Dept Med Oncol, TR-58100 Sivas, Turkey -- [Oztoprak, Ibrahim] Cumhuriyet Univ, Fac Med, Dept Radiol, TR-58100 Sivas, Turkey -- [Yucel, Birsen] Cumhuriyet Univ, Fac Med, Dept Radiat Oncol, TR-58100 Sivas, Turkeyen_US
dc.description.abstracten_US
dc.identifier.doi10.3109/0284186X.2011.644251en_US
dc.identifier.endpage546en_US
dc.identifier.issn0284-186X
dc.identifier.issue4en_US
dc.identifier.pmid22201408en_US
dc.identifier.scopus2-s2.0-84859751117en_US
dc.identifier.scopusqualityQ1
dc.identifier.startpage544en_US
dc.identifier.urihttps://dx.doi.org/10.3109/0284186X.2011.644251
dc.identifier.urihttps://hdl.handle.net/20.500.12418/9185
dc.identifier.volume51en_US
dc.identifier.wosWOS:000302732800016en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherINFORMA HEALTHCAREen_US
dc.relation.ispartofACTA ONCOLOGICAen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComplete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiformeen_US
dc.typeLetteren_US

Dosyalar